4 research outputs found

    Plate Pouring IV

    Get PDF
    From a high school biology class to a small research facility, this machine will cheaply (relative to its competitors) automatically pour a layer of agar into a large number of Petri dishes in order to grow bacteria micro-cultures. Designed to be powered within a fume hood, the user simply needs to open up the containment facility, insert stacks of Petri dishes, and pour in a batch of premade agar. Within the hour, approximately 120 Petri dishes should be layered and ready for further experimentation

    HisAK70: Progress towards a vaccine against different forms of leishmaniosis

    Get PDF
    Background: Leishmania major and Leishmania infantum are among the main species that are responsible for cutaneous leishmaniosis (CL) and visceral leishmaniosis (VL), respectively. The leishmanioses represent the second-largest parasitic killer in the world after malaria. Recently, we succeeded in generating a plasmid DNA (pCMV-HISA70m2A) and demonstrated that immunized mice were protected against L. major challenge. The efficacy of the DNA-vaccine was further enhanced by the inclusion of KMP-11 antigen into the antibiotic-free plasmid pVAX1-asd. Methods: Here, we describe the use of a HisAK70 DNA-vaccine encoding seven Leishmania genes (H2A, H2B, H3, H4, A2, KMP11 and HSP70) for vaccination of mice to assess the induction of a resistant phenotype against VL and CL. Results: HisAK70 was successful in vaccinated mice, resulting in a high amount of efficient sterile hepatic granulomas associated with a hepatic parasite burden fully resolved in the VL model; and resulting in 100 % inhibition of parasite visceralization in the CL model. Conclusions: The results suggest that immunization with the HisAK70 DNA-vaccine may provide a rapid, suitable, and efficient vaccination strategy to confer cross-protective immunity against VL and CL.This work was partially supported by grants from the Spanish Ministry of Economy and Competitiveness (AGL2010-17394 and AGL2013-44100R) and PLATESA (P2013/ABI-2906) from the Comunidad de Madrid (Spain).Peer Reviewe

    The therapeutic landscape of HIV-1 via genome editing

    No full text
    corecore